|
|
|
Insider
Information: |
Foley Todd |
Relationship: |
Director, 10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
24,224,604 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$103,031,347 |
|
|
Total
Shares |
24,224,604 |
|
|
Total
Value |
$103,031,347 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celladon Corp |
CLDN |
Director |
2014-02-04 |
0 |
2014-02-04 |
1,066,775 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,351,048 |
Premium* |
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
595,436 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
1,427,698 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Director |
2017-10-10 |
0 |
2021-03-15 |
909,258 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
4,524,425 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-07-12 |
2,242,636 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director, 10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-22 |
4 |
AS |
$20.13 |
$541,618 |
I/I |
(26,906) |
2,144,868 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-26 |
4 |
AS |
$20.47 |
$909,298 |
I/I |
(44,421) |
2,100,447 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-27 |
4 |
AS |
$20.13 |
$204,279 |
I/I |
(10,148) |
2,090,299 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-28 |
4 |
AS |
$20.19 |
$386,679 |
I/I |
(19,152) |
2,071,147 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-01 |
4 |
AS |
$20.08 |
$211,543 |
I/I |
(10,535) |
2,060,612 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-02 |
4 |
AS |
$20.23 |
$315,143 |
I/I |
(15,578) |
2,045,034 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-03 |
4 |
AS |
$20.27 |
$369,826 |
I/I |
(18,245) |
2,026,789 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-05 |
4 |
AS |
$20.00 |
$37,920 |
I/I |
(1,896) |
2,024,893 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-24 |
4 |
AS |
$25.34 |
$2,467,812 |
I/I |
(97,388) |
1,927,505 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-25 |
4 |
AS |
$25.41 |
$456,033 |
I/I |
(17,947) |
1,909,558 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2021-03-15 |
4 |
S |
$25.10 |
$25,100,000 |
I/I |
(1,000,000) |
909,258 |
0 |
- |
|
86 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|